Table 1.
The clinical characteristics of the study groups.
Endometriosis n = 54 | Control n = 30 |
p-Value | ||
---|---|---|---|---|
Age (year) | 35 (31; 37.75) | 37 (31.75; 40) | 0.11 | |
BMI (kg/m2) | 21.3 (20.5; 24.2) | 24.9 (22.6; 27.8) | 0.05 | |
Menstrual cycle phase | Proliferative | 18 (33.3%) | 11(36.7%) | 0.81 |
Secretory | 23 (42.6%) | 14 (46.7%) | 0.82 | |
Menstrual cycle disorder | 13 (24.1%) | 5 (13.3%) | 0.58 | |
Stage of endometriosis | Stage I–II | 20 (37.03%) | ||
Stage III–IV | 34 (62.97%) | |||
Type of myomas | Intramural-subserous myoma | 19 (63.3%) | ||
intramural-submucous myoma | 11 (36.7%) |
Values are presented as median Me (Q1;Q3) or as number (%).